Effector pathways regulating T cell activation

Citation
J. Favero et V. Lafont, Effector pathways regulating T cell activation, BIOCH PHARM, 56(12), 1998, pp. 1539-1547
Citations number
137
Categorie Soggetti
Pharmacology & Toxicology
Journal title
BIOCHEMICAL PHARMACOLOGY
ISSN journal
00062952 → ACNP
Volume
56
Issue
12
Year of publication
1998
Pages
1539 - 1547
Database
ISI
SICI code
0006-2952(199812)56:12<1539:EPRTCA>2.0.ZU;2-G
Abstract
Activation of T lymphocytes is a key event for an efficient response of the immune system. It requires the involvement of the T cell receptor antigen as well as costimulatory molecules such as CD28. Engagement of these recept ors through the interaction with a foreign antigen associated with major hi stocompatibility complex molecules and CD28 counter-receptors B7.1/B7.2, re spectively, results in a series of signaling cascades acting in synergy and which culminate in activation of interleukin-2 gene transcription and even tually cell proliferation. Many studies aimed at characterizing these speci fic effector pathways have been published; however, the actual signaling mo lecules that transduce activation signals from the cell membrane to the nuc leus and that directly regulate interleukin-2 gene transcription are not ye t completely defined and remain a matter of debate. In this commentary, we have attempted to analyze the results, which are sometimes diverging if not totally contradictory, characterizing effector pathways that possibly are triggered during T cell activation. (C) 1998 Elsevier Science Inc.